InspireMD, Inc. (NSPR) is a Medical - Devices company in the Healthcare sector, currently trading at $1.35. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 3 out of 7 criteria passed.
Analyst consensus target is NSPR = $6 (+307.4% upside).
Valuation: NSPR trades at a trailing Price-to-Earnings (P/E) of -2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.12.
Financials: revenue is $9M, +20.4%/yr average growth. Net income is $49M (loss), growing at -40.3%/yr. Net profit margin is -543.3% (negative). Gross margin is 29.5% (+7.9 pp trend).
Balance sheet: total debt is $2M against $55M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 5.74 (strong liquidity). Debt-to-assets is 3.2%. Total assets: $69M.
Analyst outlook: 6 / 7 analysts rate NSPR as buy (86%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 29/100 (Fail), Future 94/100 (Pass), Income 10/100 (Fail).
